The United States Trade Representative (USTR) has responded to a petition dealing with price controls imposed on coronary artery stents in India, but a representative of device makers in India have accused the Advanced Medical Technology Association of acting "in poor taste," while others in India claim the AdvaMed petition is a case of bullying. Read More
